We studied the effect of CCK-8 on BP and blood content of CGRP in rats with hypertension caused by fructose or inhibition of NO synthase with L-NAME. The decrease in the CGRP content was found during the development of fructose-induced hypertension, but not L-NAME-caused hypertension. Administration of CCK-8 to fructose-fed animals reduced BP and increased the content of CGRP. In rats with hypertension caused by NO deficit, CCK-8 lowered BP, but did not affect the content of CGRP. These findings suggest that CGRP mediates the hypotensive effect of CCK-8 in fructose-induced hypertension, but not in NO-deficient hypertension.
Similar content being viewed by others
References
Tolochko ZS, Spiridonov VK. The influence of vanilloid receptor activation by evodiamine on the cgrp contentin blood of normal and fructose-fed rats. Ross. Fiziol. Zh. 2020;106(1):110-120. https://doi.org/10.31857/S0869813919120112. Russian.
Manni L, Aloe L, Tirassa P, Finn A, Lundeberg T. Cholecystokinin-8 promotes recovery of sympathectomy induced by 6-hydroxydopamine in adult mice. Neuroreport. 2001;12(8):1621-1627. https://doi.org/10.1097/00001756-200106130-00022
Manni L, Lundeberg T, Tirassa P, Aloe L. Cholecystokinin-8 enhances nerve growth factor synthesis and promotes recovery of capsaicin-induced sensory deficit. Br. J. Pharmacol. 2000;129(4):744-750. https://doi.org/10.1038/sj.bjp.0703088
Noble F. Pharmacology of CCKRs and SAR studies of peptidic analog ligands. Curr. Top. Med. Chem. 2007;7(12):1173-1179. https://doi.org/10.2174/156802607780960447
Ruiz-Gayo M, González MC, Fernández-Alfonso S. Vasodilatory effects of cholecystokinin: new role for an old peptide? Regul. Pept. 2006;137(3):179-184. https://doi.org/10.1016/j.regpep.2006.06.006
Russell FA, King R, Smillie SJ, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol. Rev. 2014;94(4):1099-1142. https://doi.org/10.1152/physrev.00034.2013
Sánchez-Fernández C, González MC, Beart PM, Mercer LD, Ruiz-Gayo M, Fernández-Alfonso MS. A novel role for cholecystokinin: regulation of mesenteric vascular resistance. Regul. Pept. 2004;121(1-3):145-153. https://doi.org/10.1016/j.regpep.2004.04.018
Sartor DM, Verberne AJ. Cholecystokinin selectively affects presympathetic vasomotorneurons and sympathetic vasomotor outflow. Am. J. Physiol. Regul. Integr. Comp. Phy-siol. 2002;282(4):R1174-R1184. https://doi.org/10.1152/ajpregu.00500.2001
Török J. Participation of nitric oxide in different models of experimental hypertension. Physiol. Res. 2008;57(6):813-825.
Tran LT, Yuen VG, McNeill JH. The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol. Cell. Biochem. 2009;332(1-2):145-159. https://doi.org/10.1007/s11010-009-0184-4
Watson RE, Supowit SC, Zhao H, Katki KA, Dipette DJ. Role of sensory nervous system vasoactive peptides in hypertension. Braz. J. Med. Biol. Res. 2002;35(9):1033-1045. https://doi.org/10.1590/s0100-879x2002000900004
Zamami Y, Takatori S, Hobara N, Yabumae N, Tangsucharit P, Jin X, Hashikawa N, Kitamura Y, Sasaki K, Kawasaki H. Hyperinsulinemia induces hypertension associated with eurogenic vascular dysfunction resulting from abnormal perivascular innervations in rat mesenteric resistance arteries. Hypertens. Res. 2011;34(11):1190-1196. https://doi.org/10.1038/hr.2011.97
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 171, No. 5, pp. 608-612, May, 2021
Rights and permissions
About this article
Cite this article
Tolochko, Z.S., Spiridonov, V.K. Effect of Cholecystokinin-8 (CCK-8) on Blood Pressure and Blood Content of Calcitonin-Gene-Related Peptide (CGRP) in Rats with Hypertension Caused by Fructose or Inhibition of Nitric Oxide Synthesis. Bull Exp Biol Med 171, 633–637 (2021). https://doi.org/10.1007/s10517-021-05284-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-021-05284-3